[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

UY25712A1 - Benzamidas sustituidas y su aplicación en medicamentos - Google Patents

Benzamidas sustituidas y su aplicación en medicamentos

Info

Publication number
UY25712A1
UY25712A1 UY25712A UY25712A UY25712A1 UY 25712 A1 UY25712 A1 UY 25712A1 UY 25712 A UY25712 A UY 25712A UY 25712 A UY25712 A UY 25712A UY 25712 A1 UY25712 A1 UY 25712A1
Authority
UY
Uruguay
Prior art keywords
medicines
application
substituted benzamides
benzamides
substituted
Prior art date
Application number
UY25712A
Other languages
English (en)
Inventor
Tieno Germann Stefanie Zimmer
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of UY25712A1 publication Critical patent/UY25712A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/42—Oxygen atoms attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Benzamidas sustituidas de fórmula general (I) y su aplicación como medicamentos, particularmente como inmunomoduladores.
UY25712A 1998-09-24 1999-09-15 Benzamidas sustituidas y su aplicación en medicamentos UY25712A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843793A DE19843793C2 (de) 1998-09-24 1998-09-24 Substituierte Benzamide

Publications (1)

Publication Number Publication Date
UY25712A1 true UY25712A1 (es) 2001-05-31

Family

ID=7882078

Family Applications (1)

Application Number Title Priority Date Filing Date
UY25712A UY25712A1 (es) 1998-09-24 1999-09-15 Benzamidas sustituidas y su aplicación en medicamentos

Country Status (27)

Country Link
US (1) US6080742A (es)
EP (1) EP0989121B1 (es)
JP (1) JP2000095761A (es)
KR (1) KR20000023339A (es)
CN (1) CN1126741C (es)
AR (1) AR021814A1 (es)
AT (1) ATE309987T1 (es)
AU (1) AU750919B2 (es)
BR (1) BR9906070A (es)
CA (1) CA2283021A1 (es)
CO (1) CO5160263A1 (es)
CZ (1) CZ295496B6 (es)
DE (2) DE19843793C2 (es)
DK (1) DK0989121T3 (es)
ES (1) ES2251143T3 (es)
HK (1) HK1026211A1 (es)
HU (1) HUP9903216A3 (es)
IL (1) IL132012A (es)
NO (1) NO312671B1 (es)
NZ (1) NZ337531A (es)
PE (1) PE20001050A1 (es)
PL (1) PL194897B1 (es)
RU (1) RU2221783C2 (es)
SI (1) SI0989121T1 (es)
SK (1) SK283316B6 (es)
UY (1) UY25712A1 (es)
ZA (1) ZA996133B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002509A1 (de) * 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
AU2001252196A1 (en) * 2000-03-20 2001-10-03 Grunenthal G.M.B.H. Substituted benzamides
US20050226845A1 (en) * 2004-03-10 2005-10-13 Chih-Ping Liu Method of treatment using interferon-tau
US20050118138A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
US20050201981A1 (en) * 2004-03-10 2005-09-15 Chih-Ping Liu Method of optimizing treatment with interferon-tau
US7431920B2 (en) * 2000-07-19 2008-10-07 Pepgen Corporation Method of treating IL-10 deficiency
US20040247565A1 (en) * 2000-07-19 2004-12-09 Chih-Ping Liu Method of treatment using interferon-tau
US20050084478A1 (en) * 2000-10-17 2005-04-21 Chih-Ping Liu Combination therapy using interferon-tau
US20050118137A1 (en) * 2000-07-19 2005-06-02 Chih-Ping Liu Method of treatment using interferon-tau
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
WO2002068414A2 (en) * 2001-02-27 2002-09-06 The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
WO2003037365A1 (en) * 2001-11-01 2003-05-08 The Johns Hopkins University Methods and compositions for treating vascular leak using hepatocyte growth factor
DE10163595A1 (de) * 2001-12-21 2003-08-07 Gruenenthal Gmbh In 3-Position heterocyclisch substituierte Piperidin-2,6-dione
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
WO2005028436A2 (en) * 2003-09-17 2005-03-31 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Thalidomide analogs as tnf-alpha modulators
US20060078942A1 (en) * 2004-03-10 2006-04-13 Pepgen Corporation Method of treatment using interferon-tau
US20080025948A1 (en) * 2004-03-10 2008-01-31 Chih-Ping Liu Methods of Treatment Using Interferon-Tau
DE102004026703A1 (de) * 2004-05-28 2005-12-29 Grünenthal GmbH Verfahren zur Herstellung von in 3-Position heterocyclisch substituierten Piperidin-2,6-dionen
EP2004614B1 (en) * 2006-04-13 2016-10-19 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Tetrahalogenated compounds useful as inhibitors of angiogenesis
CA2722139C (en) 2008-04-23 2017-04-11 Rigel Pharmaceuticals, Inc. Carboxamide compounds for the treatment of metabolic disorders
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
KR102316961B1 (ko) * 2020-01-29 2021-10-26 프라비바이오 주식회사 면역억제제로서의 벤젠 유도체의 면역억제용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545672B2 (de) * 1965-05-08 1974-11-07 Chemie Gruenenthal Gmbh, 5190 Stolberg Dikarbonsäureimidderivate und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
PL194897B1 (pl) 2007-07-31
CN1250048A (zh) 2000-04-12
NO312671B1 (no) 2002-06-17
IL132012A (en) 2004-02-19
EP0989121A1 (de) 2000-03-29
CZ338699A3 (cs) 2000-08-16
NO994626D0 (no) 1999-09-23
AU750919B2 (en) 2002-08-01
PL335555A1 (en) 2000-03-27
CN1126741C (zh) 2003-11-05
DK0989121T3 (da) 2005-12-12
AU4886199A (en) 2000-03-30
RU2221783C2 (ru) 2004-01-20
EP0989121B1 (de) 2005-11-16
SK283316B6 (sk) 2003-05-02
CO5160263A1 (es) 2002-05-30
DE59912795D1 (de) 2005-12-22
NZ337531A (en) 2000-09-29
ATE309987T1 (de) 2005-12-15
ZA996133B (en) 2000-04-06
ES2251143T3 (es) 2006-04-16
DE19843793A1 (de) 2000-04-20
US6080742A (en) 2000-06-27
HUP9903216A3 (en) 2000-10-30
HU9903216D0 (en) 1999-11-29
SK130899A3 (en) 2000-06-12
AR021814A1 (es) 2002-08-07
DE19843793C2 (de) 2000-08-03
SI0989121T1 (sl) 2006-04-30
HK1026211A1 (en) 2000-12-08
CZ295496B6 (cs) 2005-08-17
IL132012A0 (en) 2001-03-19
JP2000095761A (ja) 2000-04-04
PE20001050A1 (es) 2000-11-18
BR9906070A (pt) 2000-08-15
HUP9903216A2 (hu) 2000-06-28
NO994626L (no) 2000-03-27
CA2283021A1 (en) 2000-03-24
KR20000023339A (ko) 2000-04-25

Similar Documents

Publication Publication Date Title
UY25712A1 (es) Benzamidas sustituidas y su aplicación en medicamentos
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
BR9801652A (pt) Resorcinil-triazinas
BR0111981A (pt) herbicidas de piridina substituìda
TR200100605T2 (tr) Arilpiperazinler ve bunların metaloproteinaz inhibe edici maddeler (MMP) olarak kullanımı
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
ES2186874T3 (es) Analogos de m-amidinofenilo como inhibidores del factor xa.
BR0116402A (pt) Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
TR200002480T2 (tr) İzaşemi tedavisi için guanidin türevleri
BR9707233A (pt) Fenantridinas
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
BR0207278A (pt) Derivados de ftalazinona-piperidina como inibidores de pde4
ATE231872T1 (de) Thiazolopyrimidinderivate
PT937074E (pt) Benzonaftiridinas como terapeutica bronquica
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
GT199900173A (es) Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia disminuida.
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
BRPI0415285A (pt) derivados de aminoalcanol
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
BRPI0415034A (pt) derivados de aminopiridina como inibidores de não-sintase induzìveis
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
PT1244643E (pt) Inibidores da triptase
DK1244614T3 (da) Tryptase-inhibitorer
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20090417